Clinical Trial

Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated October 28, 2025 (before its estimated January 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Clinical trial to assess the effect of microdroplet hyaluronic acid filler to the cheek skin (SKINVIVE™, JUVÉDERM®, Irvine, CA) on skin quality in patients undergoing medical weight loss with GLP-1 therapy.
Trial Details
NCT Number NCT07221461
Lead Sponsor Goldman, Butterwick, Fitzpatrick and Groff
Conditions Wrinkle
Enrollment 24 participants
Start Date 2025-11-01
Primary Completion 2026-01-30 (estimated)
Study Completion 2026-03-02 (estimated)
Updated on ClinicalTrials.gov 2025-10-28